Abstract purple hero image


All seminars held at 11:00 am (unless otherwise stated) in the Seminar Room, Level 5, Hodgkin Building 



Dr Martin Turner, Head of Lymphocyte Signalling, The Brabaham Institute, Brabaham Research Campus, Cambridge

 “RNA binding proteins play roles in B lymphocyte development, maintenance and activation”

(sponsor – Professor Anne Willis)


WEDNESDAY 8 FEBRUARY – postdoc seminars

Dr Farheen Raza, (Dr John Le Quesne’s Lab), MRC Toxicology Unit

“Divergent roles of elF4A1 and elF4A2 in lung cancer”



Professor Zofia Chrzanowska-Lightowlers, Mitochondrial Biology, Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University

“Human mitoribosomes – their biogenesis and behaviour”

(sponsor – Professor Anne Willis)



Dr Ragnhildur Thóra Káradóttir, Lister Institute Research Prize Fellow, Allen Distinguished Investigator & FENS-Kavli Scholar – Wellcome Trust – MRC Stem Cell Institute, University of Cambridge

“Neuronal regulation of (re)myelination”

(sponsor – Professor Anne Willis)



Dr Mark Ashe, Mechanisms of post-transcriptional control, Faculty of Biology, Medicine and Health, University of Manchester

“Stress, Translation and mRNA localisation: Messages that play together stick together”

(sponsor – Professor Martin Bushell)



Professor David Rowitch, Department of Paediatrics, Wellcome Trust MRC Cambridge Stem Cell Institute, University of Cambridge

“Early detection and development of cell-based therapeutic strategies for hypomyelinating leukodystrophies”

(sponsor – Professor Anne Willis)



Dr Sarah (Sally) Assmann, Waller Professor of Biology & Principal Investigator, Eberly College of Science,  Penn State University, Pennsylvania, USA

“Hidden codes in RNA:  in vivo genome-wide probing of RNA structure”

(sponsor – Dr John Le Quesne)


WEDNESDAY 10 MAY – postgrad seminars

Hannah Mackay and Zoe Stephenson, (Dr Patricia Muller’s Lab, Dr John Le Quesne’s Lab and Professor Anne Willis’s Lab), MRC Toxicology Unit

“Mutant p53 driven cannibalism in cancer” and “Pre-clinical detection of mitochondrial toxicity in drug development”



Professor Bertrand Joseph, Cancer Center Karolinska, Karolinska University, Stockholm, Sweden

“Guilt by association, caspase-3 regulates microglia polarisation”

(sponsors – Dr Michal Malewicz and Professor Gerry Melino)


WEDNESDAY 24 MAY – postgrad seminars

Giles Hayward, (Professor Marion MacFarlane’s Lab), MRC Toxicology Unit

“The SMAC down on liver injury”



Professor Thomas Preiss, Professor of RNA Biology, Department of Genome Sciences, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia

“RNA-binding proteomes and translation cycle dynamics”

(sponsor – Professor Martin Bushell)



Professor Aleksandra Filipovska, Head of Mitochondrial Medicine and Biology, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia

“Mitochondrial tales of mice and men”

(sponsor – Dr Kenneth Pryde)


WEDNESDAY 14 JUNE – postdoc seminars

Dr Lydia Aschauer, (Dr Patricia Muller’s Lab), MRC Toxicology Unit

“Copper and cadmium promote unfolding of wild type p53 resulting in a mutant p53 Gain-Of-Function phenotype”



Dr Daniel Murphy, Senior Lecturer, Beatson Institute for Cancer Research, Glasgow

“Phenotypic evolution in a mouse model reveals a druggable requirement for ERBB in KRAS-driven lung cancer”

(sponsor – Professor Marion MacFarlane)


WEDNESDAY 5 JULY – postgrad seminars

Ben Hawley, (Professor Martin Bushell’s Lab), MRC Toxicology Unit

“A role for Drosha and RNA in DNA damage repair”



Dr Ivan Topisirovic, Investigator, Lady Davis Institute, SMBD Jewish General Hospital, Assistant Professor, Dept of Oncology, McGill University, Montreal, Canada

“Dysregulation of mRNA translation and energy metabolism in cancer”

(sponsor – Professor Anne Willis)



Dr Marco M Candeias, Investigator, The Molecular and RNA Cancer Unit, Kyoto Lab, Kyoto University, Japan

Cancer-specific mutations induce cap-independent expression of short p53 isoform leading to cancer cell survival and invasion

(sponsor – Professor Gerry Melino)


WEDNESDAY 27 SEPTEMBER – postdoc seminars

Dr Ania Wilczynska , (Professor Martin Bushell’s Lab), MRC Toxicology Unit

“Dual modes of translational repression by DEAD-box proteins


WEDNESDAY 11 OCTOBER – postdoc seminars

Dr Rob Harvey, (Professor Anne Willis’s Lab), MRC Toxicology Unit

Title – TBC


WEDNESDAY 25 OCTOBER – postdoc/post grad seminars

Dr Clement Soleilhavoup & Kieran Patrick, (Dr Lia Panman’s Lab), MRC Toxicology Unit

Titles – TBC


WEDNESDAY 1 NOVEMBER – postdoc seminars

Dr Joseph Waldron, (Dr John Le Quesne’s Lab), MRC Toxicology Unit

Title – TBC



Dr Edmund Kunji, Programme Leader, MRC Mitochondrial Biology Unit, Cambridge

Title – TBC

(sponsor – Dr Kenneth Pryde)


WEDNESDAY 15 NOVEMBER – postdoc seminars

Dr Pedro Garcao, (Dr Lia Panman’s Lab), MRC Toxicology Unit

Title – TBC



Professor Thomas Langer, Head of Research Area A – Principal Investigator, Deputy Scientific Coordinator – Institute for Genetics, University of Cologne, CECAD Research Center, Germany

“Proteolytic control of mitochondrial function”

(sponsor – Dr Kenneth Pryde)



Dr Stephan Vagner, INSERM Research Director, Institut Curie-Centre de Recherche, Université Paris, France

“mRNA translation and resistance to anti-cancer targeted therapies”

(sponsor – Professor Anne Willis)



Professor Vladimir Botchkarev, Professor of Cutaneous Biology, Centre for Skin Sciences & Deputy Director, Bradford School of Chemistry and Bioscience, Centre for Skin Sciences, University of Bradford 

Title – TBC

(sponsor – Professor Gerry Melino)









Latest News

Latest Tweets